Abstract:Protein aggregation induces profound changes in the structure along with the conformation of the protein, and is responsible for the pathogenesis of a number of neurodegenerative conditions such as Huntington's, Creutzfeldt–Jacob, Type II diabetes mellitus, Alzheimer's, etc. Numerous multi-spectroscopic approaches and in-silico experiments were utilized to investigate BSA's biomolecular interaction and aggregation in the presence of quinoline yellow. The present research investigation evaluated the interaction of BSA with the food colorant (QY) at two different pH (7.4 and 2.0). The development of the BSA-QY complex was established with UV visible and fluorescence spectroscopy. The quenching of fluorescence upon the interaction of BSA with QY revealed the static nature of quenching mechanism. The K b value obtained from our result is 4. 54 × 10 −4 M −1 . The results from the competitive site marker study infer that quinoline yellow is binding with the sub-domain IB of bovine serum albumin, specifically on site III. Three-dimensional fluorescence and synchronous fluorescence spectroscopy were applied for monitoring the alterations in the microenvironment of BSA upon the addition of quinoline yellow. The results from turbidity and RLS studies showed that higher concentrations of QY (80–400 μM) triggered bovine serum albumin (BSA) aggregation at pH 2.0. At pH 7.4, QY couldn't manage to trigger bovine serum albumin aggregation, perhaps because of the repulsion between negatively charged dye (QY) and anionic bovine serum albumin. The results from far-UV CD, Congo Red, and scanning electron microscopy implicate that the QY-induced aggregates exhibit amyloid fibril-like structures. Molecular docking results revealed that hydrophobic interactions, hydrogen bonding, and Pi-Sulfur interactions contribute to QY-induced aggregation of BSA. Further, the amyloid inhibitory potential of ferulic acid (FA), a phenolic acid on QY-induced aggregation of BSA, has also been assessed. The QY-induced amyloid fibrils are FA-soluble, as confirmed by turbidity, RLS, and far-UV CD studies. Far-UV CD results showed that FA retains α helix and inhibits cross β sheet formation when the aggregated samples were pre-incubated with increasing concentrations of FA (0–500 μM). Our findings conclude that QY dye successfully stimulates BSA aggregation, but ferulic acid inhibits QY-induced aggregation of BSA. Thus, FA can serve as a therapeutic agent and can help in the treatment of various amyloid-related conditions.

Quinoline yellow acts as a novel amyloid fibrillation probe by using surface-enhanced Raman spectroscopy

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

A Near-Infrared Fluorescent Probe Quinaldine Red Lights Up the Β-Sheet Structure of Amyloid Proteins in Mouse Brain.

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

Fluorogenic sensing of amorphous aggregates, amyloid fibers, and chaperone activity via a near‐infrared aggregation‐induced emission‐active probe

In Vivo and in Vitro Monitoring of Amyloid Aggregation Via BSA@FGQDs Multimodal Probe.

Turn-on Fluorescence Probing of Amyloid Fibrils by the Proto-Berberine Alkaloids and the Study of Their Interactions

Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging

Investigating the binding interaction of quinoline yellow with bovine serum albumin and anti-amyloidogenic behavior of ferulic acid on QY-induced BSA fibrils

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin

Crocein Orange G Mediated Detection and Modulation of Amyloid Fibrillation Revealed by Surface-Enhanced Raman Spectroscopy.

Effects of Several Quinones on Insulin Aggregation

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.

Fluorescent Silicon Nanoparticles Inhibit the Amyloid Fibrillation of Insulin

A Redox Cycle Meets Insulin Fibrillation in Vitro.

A Novel Aggregation-Induced Emission Fluorescent Probe for Detection of Β-Amyloid Based on Pyridinyltriphenylamine and Quinoline–Malononitrile

Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators.

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

Monitoring and Modulation of Insulin Fibers by a Protein Isomerization Targeting Dye Bromophenol Blue

A Pyridyl Zn (II) Chelate for the Sensitive Detection of Aβ Fibrils

A Ratiometric Fluorescent Conjugated Oligomer for Amyloid Β Recognition, Aggregation Inhibition, and Detoxification.